Manufacturers Life Insurance Company, The Protagonist Therapeutics, Inc Transaction History

Manufacturers Life Insurance Company, The

  • $109 Billion
  • Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 124,341 shares of PTGX stock, worth $6.55 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
124,341
Previous 115,765 7.41%
Holding current value
$6.55 Million
Previous $5.2 Million 7.75%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$38.51 - $48.43 $330,261 - $415,335
8,576 Added 7.41%
124,341 $4.8 Million
Q3 2024

Nov 13, 2024
BUY
$33.72 - $47.33 $45,825 - $64,321
1,359 Added 1.19%
115,765 $5.2 Million
Q2 2024

Aug 14, 2024
BUY
$24.66 - $34.8 $610,310 - $861,265
24,749 Added 27.6%
114,406 $3.96 Million
Q1 2024

May 14, 2024
BUY
$21.79 - $32.15 $462,492 - $682,383
21,225 Added 31.02%
89,657 $2.59 Million
Q4 2023

Feb 13, 2024
SELL
$14.05 - $23.44 $79,958 - $133,397
-5,691 Reduced 7.68%
68,432 $1.57 Million
Q3 2023

Nov 15, 2023
BUY
$16.68 - $23.66 $137,293 - $194,745
8,231 Added 12.49%
74,123 $1.24 Million
Q2 2023

Aug 11, 2023
BUY
$18.02 - $29.36 $853,679 - $1.39 Million
47,374 Added 255.83%
65,892 $1.82 Million
Q1 2023

May 15, 2023
BUY
$10.78 - $25.38 $283,912 - $668,433
26,337 Added 142.22%
44,855 $1.03 Million
Q4 2022

Aug 11, 2023
SELL
$7.36 - $11.17 $397 - $603
-54 Reduced 0.29%
18,518 $202,000
Q4 2022

Feb 13, 2023
SELL
$7.36 - $11.17 $397 - $603
-54 Reduced 0.29%
18,518 $202,000
Q3 2022

Aug 11, 2023
SELL
$7.86 - $11.71 $6,413 - $9,555
-816 Reduced 4.21%
18,572 $156,000
Q3 2022

Nov 03, 2022
SELL
$7.86 - $11.71 $6,413 - $9,555
-816 Reduced 4.21%
18,572 $157,000
Q2 2022

Aug 11, 2023
SELL
$7.06 - $25.52 $148,168 - $535,588
-20,987 Reduced 51.98%
19,388 $153,000
Q2 2022

Aug 15, 2022
SELL
$7.06 - $25.52 $148,168 - $535,588
-20,987 Reduced 51.98%
19,388 $153,000
Q1 2022

Aug 11, 2023
SELL
$23.34 - $36.08 $104,563 - $161,638
-4,480 Reduced 9.99%
40,375 $956,000
Q1 2022

May 20, 2022
BUY
$23.34 - $36.08 $409,687 - $633,312
17,553 Added 76.91%
40,375 $961,000
Q4 2021

Feb 16, 2022
SELL
$17.63 - $37.1 $13,381 - $28,158
-759 Reduced 3.22%
22,822 $781,000
Q3 2021

Nov 12, 2021
BUY
$12.95 - $49.69 $7,200 - $27,627
556 Added 2.41%
23,581 $418,000
Q2 2021

Aug 12, 2021
BUY
$25.57 - $44.88 $76,352 - $134,011
2,986 Added 14.9%
23,025 $1.03 Million
Q1 2021

May 03, 2021
BUY
$19.02 - $31.15 $19,476 - $31,897
1,024 Added 5.39%
20,039 $519,000
Q4 2020

Feb 12, 2021
BUY
$18.49 - $25.13 $34,206 - $46,490
1,850 Added 10.78%
19,015 $383,000
Q3 2020

Nov 09, 2020
BUY
$15.19 - $22.4 $53,013 - $78,176
3,490 Added 25.52%
17,165 $336,000
Q2 2020

Aug 10, 2020
BUY
$6.19 - $18.84 $9,130 - $27,789
1,475 Added 12.09%
13,675 $238,000
Q1 2020

May 15, 2020
BUY
$5.4 - $9.22 $5,427 - $9,266
1,005 Added 8.98%
12,200 $86,000
Q4 2019

Feb 14, 2020
BUY
$4.69 - $13.45 $984 - $2,824
210 Added 1.91%
11,195 $79,000
Q3 2019

Nov 12, 2019
BUY
$9.41 - $16.56 $1,402 - $2,467
149 Added 1.38%
10,985 $144,000
Q2 2019

Aug 14, 2019
BUY
$8.98 - $12.96 $97,307 - $140,434
10,836 New
10,836 $131,000
Q3 2018

Nov 14, 2018
SELL
$6.82 - $11.26 $3,962 - $6,542
-581 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$5.99 - $9.1 $51,136 - $77,686
-8,537 Reduced 93.63%
581 $4,000
Q1 2018

May 15, 2018
SELL
$8.46 - $23.08 $2,580 - $7,039
-305 Reduced 3.24%
9,118 $78,000
Q4 2017

Feb 08, 2018
BUY
$14.47 - $20.8 $7,770 - $11,169
537 Added 6.04%
9,423 $196,000
Q3 2017

Nov 14, 2017
BUY
$10.61 - $17.98 $94,280 - $159,770
8,886
8,886 $158,000

Others Institutions Holding PTGX

# of Institutions
254
Shares Held
58.9M
Call Options Held
226K
Put Options Held
218K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2.58B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email